1069379

Wuhan Biocause Pharmaceutical Development Co., Ltd. — FEI 3004202226

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 24, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wuhan (China)